Back to All News

Robinson, Schwarz Recognized by ASTRO

By Siteman Communications |

Two Washington University School of Medicine professors of radiation oncology – Clifford G. Robinson, MD, and Julie K. Schwarz, MD, PhD – have been named fellows of the American Society for Radiation Oncology (ASTRO). Additionally, Robinson has been elected to the ASTRO Board of Directors.

Julie K. Schwarz MD PhD
Julie K. Schwarz, MD, PhD

ASTRO counts more than 10,000 members worldwide, including physicians, nurses, physicists and other specialists. The society’s mission is to advance care, education, professional development and research in the radiation oncology field. Jeff Michalski, MD, the Carlos A. Perez Distinguished Professor and vice chair and director of Clinical Programs in the Department of Radiation Oncology at the School of Medicine, is chair and the immediate past president of the ASTRO Board of Directors.

 

 

 

The ASTRO fellows program recognizes individuals who have made substantial contributions to the society and to the field of radiation oncology through research, education, patient care and service. Robinson and Schwarz will be recognized Oct. 1 at an awards ceremony during ASTRO’s 66th Annual Meeting, in Washington, D.C.

Clifford G. Robinson, MD
Clifford G. Robinson, MD

As a member of the ASTRO Board of Directors, Robinson will serve on the nominating committee, which is responsible for presenting board candidates for election.

Michalski, Robinson and Schwarz treat patients at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine.

Schwarz is the vice chair for research and director of the Cancer Biology Division in radiation oncology. She treats women with locally advanced cervical cancer.

Robinson is chief of Cardiothoracic Radiation Oncology and Stereotactic Radiotherapy, and associate director of Clinical Programs. His clinical practice includes thoracic oncology and stereotactic radiotherapy.

The two co-lead Washington University’s MicroEnvironment and Tumor Effects of Radiotherapy Center (METEOR), one of only five centers in a National Institutes of Health (NIH) network aimed at understanding the biologic effects of radiation therapy in cancer treatment.